Apellis Pharmaceuticals Correlations

APLS Stock

USD 23.78 0.48 1.98%

The current 90-days correlation between Apellis Pharmaceuticals and Akero Therapeutics is 0.08 (i.e., Significant diversification). The correlation of Apellis Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Apellis Pharmaceuticals Correlation With Market

Weak diversification

The correlation between Apellis Pharmaceuticals and DJI is 0.3 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apellis Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Apellis Stock please use our How to Invest in Apellis Pharmaceuticals guide.

Moving together with Apellis Stock

0.84	CDIOW	Cardio Diagnostics	Pair Corr
0.84	ELVN	Enliven Therapeutics Downward Rally	Pair Corr
0.84	SCLX	Scilex Holding	Pair Corr
0.88	ASMB	Assembly Biosciences Earnings Call Tomorrow	Pair Corr
0.82	CDIO	Cardio Diagnostics	Pair Corr
0.61	CMND	Clearmind Medicine Common	Pair Corr
0.89	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.61	CAT	Caterpillar	Pair Corr
0.64	DIS	Walt Disney	Pair Corr
0.85	MSFT	Microsoft Aggressive Push	Pair Corr

Moving against Apellis Stock

0.82	WM	Waste Management	Pair Corr
0.81	LUCD	Lucid Diagnostics	Pair Corr
0.71	GE	GE Aerospace	Pair Corr
0.56	PLX	Protalix Biotherapeutics	Pair Corr
0.41	PG	Procter Gamble	Pair Corr
0.87	JNJ	Johnson Johnson	Pair Corr
0.84	T	ATT Inc Aggressive Push	Pair Corr
0.77	CVX	Chevron Corp	Pair Corr
0.75	MMM	3M Company	Pair Corr
0.66	XOM	Exxon Mobil Corp Earnings Call This Week	Pair Corr
0.65	IBM	International Business	Pair Corr
0.58	CSCO	Cisco Systems	Pair Corr
0.54	INTC	Intel Sell-off Trend	Pair Corr

Related Correlations Analysis

	RXDX	AKRO	IMVT	MDGL	DAWN	MRTX	AMLX	TERN	XFOR	INZY
RXDX		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RXDX
AKRO	0.0		-0.73	0.64	-0.26	0.0	-0.31	-0.59	-0.35	-0.61	AKRO
IMVT	0.0	-0.73		-0.61	0.68	0.0	0.56	0.93	0.75	0.86	IMVT
MDGL	0.0	0.64	-0.61		-0.37	0.0	-0.09	-0.5	-0.33	-0.43	MDGL
DAWN	0.0	-0.26	0.68	-0.37		0.0	0.24	0.75	0.81	0.59	DAWN
MRTX	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	MRTX
AMLX	0.0	-0.31	0.56	-0.09	0.24	0.0		0.61	0.46	0.66	AMLX
TERN	0.0	-0.59	0.93	-0.5	0.75	0.0	0.61		0.85	0.93	TERN
XFOR	0.0	-0.35	0.75	-0.33	0.81	0.0	0.46	0.85		0.82	XFOR
INZY	0.0	-0.61	0.86	-0.43	0.59	0.0	0.66	0.93	0.82		INZY
	RXDX	AKRO	IMVT	MDGL	DAWN	MRTX	AMLX	TERN	XFOR	INZY

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

TERN	+ 0.93	IMVT
INZY	+ 0.93	TERN
INZY	+ 0.86	IMVT
XFOR	+ 0.85	TERN
INZY	+ 0.82	XFOR
XFOR	+ 0.81	DAWN

High negative correlations

IMVT	- 0.73	AKRO
MDGL	- 0.61	IMVT
INZY	- 0.61	AKRO
TERN	- 0.59	AKRO
TERN	- 0.5	MDGL
INZY	- 0.43	MDGL

Risk-Adjusted Indicators

There is a big difference between Apellis Stock performing well and Apellis Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Apellis Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
RXDX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
AKRO	4.31	1.20	0.35	0.73	2.88	(5.92)	4.92	(5.64)	104.81
IMVT	2.40	(0.46)	0.00	(0.56)	0.00	0.00	4.29	(5.95)	18.14
MDGL	2.99	0.28	0.07	0.21	3.97	(2.99)	7.64	(5.66)	23.14
DAWN	2.88	(0.52)	0.00	(0.61)	0.00	0.00	6.36	(6.67)	22.86
MRTX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
AMLX	3.67	0.00	0.00	(0.04)	0.00	0.00	7.20	(9.09)	21.45
TERN	3.07	(0.93)	0.00	(0.94)	0.00	0.00	5.03	(6.98)	19.13
XFOR	6.28	(0.68)	0.00	(2.46)	0.00	0.00	10.87	(13.51)	68.45
INZY	4.12	(1.40)	0.00	(0.80)	0.00	0.00	6.82	(9.17)	36.29

Apellis Pharmaceuticals Corporate Management

James CPA	Corporate VP	Profile
Cedric MD	President, CoFounder	Profile
Adam Townsend	Chief Commercial Officer	Profile
Karen Lewis	Chief Officer	Profile
Nur Nicholson	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC